These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24522831)

  • 21. The p38 MAPK inhibitor JLU1124 inhibits the inflammatory response induced by lipopolysaccharide through the MAPK-NF-κB pathway in RAW264.7 macrophages.
    Li XN; Su J; Zhao L; Xiang JB; Wang W; Liu F; Li HY; Zhong JT; Bai X; Sun LK
    Int Immunopharmacol; 2013 Nov; 17(3):785-92. PubMed ID: 24070708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benzoxathiole derivative blocks lipopolysaccharide-induced nuclear factor-kappaB activation and nuclear factor-kappaB-regulated gene transcription through inactivating inhibitory kappaB kinase beta.
    Kim BH; Roh E; Lee HY; Lee IJ; Ahn B; Jung SH; Lee H; Han SB; Kim Y
    Mol Pharmacol; 2008 Apr; 73(4):1309-18. PubMed ID: 18202307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cryptopleurine targets NF-κB pathway, leading to inhibition of gene products associated with cell survival, proliferation, invasion, and angiogenesis.
    Jin HR; Jin SZ; Cai XF; Li D; Wu X; Nan JX; Lee JJ; Jin X
    PLoS One; 2012; 7(6):e40355. PubMed ID: 22768286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. O-Methylbulbocapnine and Dicentrine Suppress LPS-Induced Inflammatory Response by Blocking NF-κB and AP-1 Activation through Inhibiting MAPKs and Akt Signaling in RAW264.7 Macrophages.
    Yodkeeree S; Ooppachai C; Pompimon W; Limtrakul Dejkriengkraikul P
    Biol Pharm Bull; 2018; 41(8):1219-1227. PubMed ID: 30068871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Compound FLZ inhibits lipopolysaccharide-induced inflammatory effects via down-regulation of the TAK-IKK and TAK-JNK/p38MAPK pathways in RAW264.7 macrophages.
    Pang HY; Liu G; Liu GT
    Acta Pharmacol Sin; 2009 Feb; 30(2):209-18. PubMed ID: 19169268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 15-epi-lipoxin A
    Chen Y; Zheng Y; Xin L; Zhong S; Liu A; Lai W; Liu L; Lin C; Liao C; Zeng J; Zhang L
    Biomed Pharmacother; 2019 Sep; 117():109099. PubMed ID: 31200255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blockade of nuclear factor-kappaB signaling pathway and anti-inflammatory activity of cardamomin, a chalcone analog from Alpinia conchigera.
    Lee JH; Jung HS; Giang PM; Jin X; Lee S; Son PT; Lee D; Hong YS; Lee K; Lee JJ
    J Pharmacol Exp Ther; 2006 Jan; 316(1):271-8. PubMed ID: 16183703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Euscaphic acid isolated from roots of Rosa rugosa inhibits LPS-induced inflammatory responses via TLR4-mediated NF-κB inactivation in RAW 264.7 macrophages.
    Kim IT; Ryu S; Shin JS; Choi JH; Park HJ; Lee KT
    J Cell Biochem; 2012 Jun; 113(6):1936-46. PubMed ID: 22234926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipoxin A4 regulates M1/M2 macrophage polarization via FPR2-IRF pathway.
    Yuan J; Lin F; Chen L; Chen W; Pan X; Bai Y; Cai Y; Lu H
    Inflammopharmacology; 2022 Apr; 30(2):487-498. PubMed ID: 35235107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipoxin A4 suppresses osteoclastogenesis in RAW264.7 cells and prevents ovariectomy-induced bone loss.
    Liu C; Guan H; Cai C; Li F; Xiao J
    Exp Cell Res; 2017 Mar; 352(2):293-303. PubMed ID: 28209487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipoxin A4 attenuation of endothelial inflammation response mimicking pancreatitis-induced lung injury.
    Lv W; Lv C; Yu S; Yang Y; Kong H; Xie J; Sun H; Andersson R; Xu D; Chen B; Zhou M
    Exp Biol Med (Maywood); 2013 Dec; 238(12):1388-95. PubMed ID: 24000382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory effect of sulphated polysaccharide porphyran on nitric oxide production in lipopolysaccharide-stimulated RAW264.7 macrophages.
    Jiang Z; Hama Y; Yamaguchi K; Oda T
    J Biochem; 2012 Jan; 151(1):65-74. PubMed ID: 21976706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progranulin inhibits LPS-induced macrophage M1 polarization via NF-кB and MAPK pathways.
    Liu L; Guo H; Song A; Huang J; Zhang Y; Jin S; Li S; Zhang L; Yang C; Yang P
    BMC Immunol; 2020 Jun; 21(1):32. PubMed ID: 32503416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipoxin A4 inhibits TNF-alpha-induced production of interleukins and proliferation of rat mesangial cells.
    Wu SH; Lu C; Dong L; Zhou GP; He ZG; Chen ZQ
    Kidney Int; 2005 Jul; 68(1):35-46. PubMed ID: 15954894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Saikosaponin B2 Suppresses Inflammatory Responses Through IKK/IκBα/NF-κB Signaling Inactivation in LPS-Induced RAW 264.7 Macrophages.
    Shin JS; Im HT; Lee KT
    Inflammation; 2019 Feb; 42(1):342-353. PubMed ID: 30251218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipoxin A4 exerts protective effects against experimental acute liver failure by inhibiting the NF-κB pathway.
    Jiang X; Li Z; Jiang S; Tong X; Zou X; Wang W; Zhang Z; Wu L; Tian D
    Int J Mol Med; 2016 Mar; 37(3):773-80. PubMed ID: 26865215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PMC, a potent hydrophilic α-tocopherol derivative, inhibits NF-κB activation via PP2A but not IκBα-dependent signals in vascular smooth muscle cells.
    Hsieh CY; Hsiao G; Hsu MJ; Wang YH; Sheu JR
    J Cell Mol Med; 2014 Jul; 18(7):1278-89. PubMed ID: 24725826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. VEGF expression in human macrophages is NF-kappaB-dependent: studies using adenoviruses expressing the endogenous NF-kappaB inhibitor IkappaBalpha and a kinase-defective form of the IkappaB kinase 2.
    Kiriakidis S; Andreakos E; Monaco C; Foxwell B; Feldmann M; Paleolog E
    J Cell Sci; 2003 Feb; 116(Pt 4):665-74. PubMed ID: 12538767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methyl-1-hydroxy-2-naphthoate, a novel naphthol derivative, inhibits lipopolysaccharide-induced inflammatory response in macrophages via suppression of NF-κB, JNK and p38 MAPK pathways.
    Zhang JY; Jin H; Wang GF; Yu PJ; Wu SY; Zhu ZG; Li ZH; Tian YX; Xu W; Zhang JJ; Wu SG
    Inflamm Res; 2011 Sep; 60(9):851-9. PubMed ID: 21667204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoxin A4 inhibits lipopolysaccharide-induced production of inflammatory cytokines in keratinocytes by up-regulating SOCS2 and down-regulating TRAF6.
    Hu F; Feng AP; Liu XX; Zhang S; Xu JT; Wang X; Zhong XL; He MW; Chen HX
    J Huazhong Univ Sci Technolog Med Sci; 2015 Jun; 35(3):426-431. PubMed ID: 26072084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.